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Summary
Ghrelin, a gastrointestinal peptide, stimulates feeding when administered peripherally. Blockade of the vagal afferent path-
way abolishes ghrelin-induced feeding, indicating that the vagal afferent pathwaymay be a route conveying orexigenic ghre-
lin signals to the brain. Here, we demonstrate that peripheral ghrelin signaling, which travels to the nucleus tractus solitarius
(NTS) at least in part via the vagus nerve, increases noradrenaline (NA) in the arcuate nucleus of the hypothalamus, thereby
stimulating feeding at least partially through a-1 and b-2 noradrenergic receptors. In addition, bilateral midbrain transections
rostral to the NTS, or toxin-induced loss of neurons in the hindbrain that express dopamine b hydroxylase (an NA synthetic
enzyme), abolished ghrelin-induced feeding. These findings provide new evidence that the noradrenergic system is neces-
sary in the central control of feeding behavior by peripherally administered ghrelin.Introduction
Ghrelin, a newly discovered member of the family of gut-brain
peptides, functions in feeding control and growth hormone
(GH) secretion by binding to the growth hormone secretagogue
receptor (GHS-R) (Kojima et al., 1999; Nakazato et al., 2001;
Tscho¨p et al., 2000; Wren et al., 2000). This peptide, which is
produced primarily by endocrine cells of the stomach, is re-
leased into the circulation (Date et al., 2000; Dornonville de la
Cour et al., 2001). Ghrelin is also produced by neurons of the
hypothalamus, where it serves as part of the neural networks
(Cowley et al., 2003). GHS-R is extensively distributed through-
out the brain, including the hypothalamus and brainstem where
are essential for energy homeostasis. Given the GHS-R expres-
sion pattern, ghrelin, when given centrally, peripherally, or both,
may increase food intake directly via effects on neurons present
in the hypothalamus or brainstem. We recently demonstrated,
however, that blockade of the gastric vagal afferent path-
way abolished peripheral ghrelin-induced feeding (Date et al.,
2002). A similar study demonstrated that intraperitoneal injec-
tion of ghrelin into vagotomized mice did not stimulate food in-
take (Asakawa et al., 2001). These findings suggest that the gas-
tric vagal afferent pathway as well as the humoral pathway may
have some significant part in conveying ghrelin-mediated orexi-
genic signals to the brain.
Several gastrointestinal hormones, including ghrelin, chole-
cystokinin (CCK), peptide YY, and glucagon-like peptide 1,CELL METABOLISM 4, 323–331, OCTOBER 2006 ª2006 ELSEVIER INtransmit signals of starvation and satiety to the brain at least in
part via the vagal afferent system (Date et al., 2002; Smith
et al., 1981; Koda et al., 2005; Abbott et al., 2005). Feeding-
related information, travels directly to the nucleus tractus
solitarius (NTS), where it can be converted to additional signals
that transmit a feeling of hunger or fullness to the hypothalamus.
In the present study, we focused on the importance of the neural
pathways from the NTS to the hypothalamus in transmitting
peripheral ghrelin signals.
To investigate the neural pathways involved in the transmis-
sion of ghrelin orexigenic signals from the NTS to the hypothal-
amus, we examined the effects of bilateral midbrain transec-
tions on ghrelin-induced feeding. The NTS contains the A2
noradrenergic cell group, which projects to regions of the hypo-
thalamus that include the arcuate nucleus (ARC) (Sawchenko
and Swanson, 1981). Therefore, we examined the role of the
central noradrenaline (NA) system in peripheral ghrelin feeding
stimulation. Using real-time PCRs, we quantified the expression
of dopamine b hydroxylase (DBH), an enzyme necessary to con-
vert dopamine into NA, within the NTS. We also measured over-
flow NA within or near the ARC after intravenous administration
of ghrelin using in vivo microdialysis. We studied the effects of
adrenergic antagonists and the elimination of NA innervation
within the ARC on ghrelin-induced food intake. Using immuno-
histochemical techniques, we demonstrated that the NPY neu-
rons activated following intravenous administration of ghrelin
are innervated by DBH-containing fibers.C. DOI 10.1016/j.cmet.2006.09.004 323
S H O R T A R T I C L EFigure 1. Effect of bilateral midbrain transections on ghrelin-induced feeding behavior
A) Two hour food intake (mean 6 SEM) of sham-treated rats after a single intravenous administration of ghrelin (0.1–100 mg/kg). *p < 0.0001 versus saline.
B) Food intake of rats with bilateral midbrain transections after a single intravenous administration of ghrelin (15 and 50 mg/kg). *p < 0.0001.
C) Food intake of rats with bilateral midbrain transections after single intracerebroventricular administration of ghrelin (5 mg/kg). *p < 0.0001.
Error bars represent the SEM.Results and Discussion
Midbrain transections and peripheral
ghrelin-induced feeding
To investigate if intravenous administration of ghrelin stimu-
lates feeding via the ascending efferent fibers of the NTS, we
examined ghrelin-induced food intake in rats with bilateral
midbrain transections (Crawley et al. 1984). Before this exper-
iment, we confirmed that there were no significant differences
in body weight or food intake between control and actual
transected groups up to eight days after the surgery (see
Supplemental Results and Figure S1 in the Supplemental
Data available with this article online). There were also no
significant differences in the feeding response after fasting
for 12 hr, energy expenditure, locomotor activity, body fat, or
food preference between the two groups seven days after
surgery (Supplemental Results and Figure S2). Therefore, we
performed feeding experiments using rats seven days after
the surgery. The lowest effective dose of intravenously (i.v.) ad-
ministered ghrelin for rats subjected to sham surgery (sham-
treated rats) was 15 mg/kg; this value was used as the standard
dose in the subsequent experiments (Figure 1A). Intravenous
administration of ghrelin (R 15 mg/kg) significantly increased
food intake (10:00–12:00 hr) in sham-treated rats, whereas324ghrelin-induced feeding was absent in midbrain transected
rats (Figure 1B) (n = 10 per group). Because bilateral midbrain
transections may nonspecifically suppress feeding in response
to ghrelin, we tested the orexigenic effect of centrally adminis-
tered ghrelin in the midbrain transected rats. Intracerebroven-
tricular administration of ghrelin similarly increased food intake
in the transected and control groups (Figure 1C) (n = 7 per
group). This finding demonstrates that bilateral midbrain tran-
sections specifically blocked peripherally administered ghre-
lin-induced feeding, but did not affect centrally administered
ghrelin-induced feeding. Centrally and peripherally adminis-
tered ghrelin may therefore stimulate feeding by distinct mech-
anisms. Midbrain transections severing the ascending efferent
fibers of the NTS block feeding reduction of CCK that transmits
satiety signals to the brain via the afferent limb of the vagus
nerve (Crawley et al., 1984). In contrast, Grill and Smith
showed that CCK-induced feeding reduction is still observed
in chronic decerebrate rats (Grill and Smith, 1988). We de-
scribed some differences in the surgery between midbrain
transection and chronic decerebration in Supplementary
Methods (Grill and Norgren, 1978) (Supplemental Experimental
Procedures).
We have already shown the possibility that peripheral ghrelin
signals for starvation are transmitted to the neuropeptide YCELL METABOLISM : OCTOBER 2006
Noradrenergic signaling in ghrelin-induced feedingFigure 2. Ghrelin stimulates feeding via the NA system
A) DBH mRNA levels in rats receiving either ghrelin (15 mg/kg, i.v.) or saline. *p < 0.03 versus saline.
B) Effect of intravenous ghrelin on NA levels within the ARC in sham-treated and midbrain-transected rats. NA levels are represented as percentages of the mean con-
centration of NA in four consecutive dialysate samples taken before ghrelin injection. *p < 0.01, **p < 0.0001 versus sham saline.
Error bars represent the SEM.neurons of the ARC at least partially via the vagal afferent path-
way (Date et al., 2002). The possibility remains, however, that i.v.
administered ghrelin may bind directly to receptors present on
neurons in the ARC, as the ARC, situated at the base of the
hypothalamus, is incompletely isolated from the general circula-
tion by the blood-brain barrier (Banks and Kastin, 1985; Mer-
chenthaler, 1991). The present study shows that ghrelin-in-
duced feeding was abrogated in transected rats. This result
indicates that neural pathways ascending from the NTS may
play an important role in the transmission of ghrelin orexigenic
signals to the hypothalamus. Conveyed to the NTS, these sig-
nals could be relayed to the hypothalamus through other trans-
mitters produced by neurons located in the NTS.
NA system and peripheral ghrelin-induced feeding
Although afferent projections from the NTS to the hypothalamus
are not exclusively noradrenergic, the noradrenergic pathway is
the major constituent. We here showed that DBH mRNA levels
increased significantly in the NTS after ghrelin (15 mg/kg) admin-
istration (Figure 2A). Considering that the NTS is the termination
area of the vagal afferent fibers that receive vicerosensory infor-
mation from the gastrointestinal tract, it seems reasonable to ex-
pect that peripheral ghrelin induces Fos expression in the NTS.
We were not, however, able to detect any increase in the num-
ber of Fos-expressing neurons in the NTS (Date et al., 2005).
This finding is consistent with previous data from other groups
(Wang et al., 2002; Ru¨ter et al., 2003). These results may depend
on the fact that peripherally administered ghrelin decreases the
firing rate of gastric vagal afferent fibers by binding to its recep-
tor present in the vagal afferent terminals (Asakawa et al., 2001;
Date et al., 2002). Thus, inhibitory signals caused by peripherally
administered ghrelin may affect DBH expression in the NTS.
Peripherally administered ghrelin and synthetic GHSs primar-
ily activate neurons located in the ARC (Hewson and Dickson,
2000). Most peripheral ghrelin-induced Fos-positive neurons in
the ARC express NPY (Wang et al., 2002; Date et al., 2002).
NPY and agouti-related protein (AgRP), which are colocalized
in neurons of the ARC, have been implicated in the stimulation
of feeding behavior. Pharmacological examinations indicated
that centrally administered NPY Y-1 receptor antagonists blockCELL METABOLISM : OCTOBER 2006the orexigenic effect of ghrelin injected peripherally (Asakawa
et al., 2001). Furthermore, Chen et al. demonstrated that periph-
erally administered ghrelin does not induce food intake in
NPY2/2, AgRP2/2 double-knockout mice (Chen et al., 2004).
These findings suggest that the ARC plays a crucial role in reg-
ulating peripheral ghrelin signals. In order to examine whether
peripherally administered ghrelin affects the release of NA in
the ARC, which is not only a noradrenergic terminal area but
also a target site of peripheral ghrelin signals, we monitored
overflow NA within or near the ARC using a microdialysis sys-
tem. Overflow NA is thought to include both newly released
NA and NA that was not subject to reuptake. Examination of
overflow NA within or near the ARC after intravenous administra-
tion of 15 and 30 mg/kg ghrelin to sham-treated rats (n = 7 per
group) revealed significantly increased NA concentrations
within and near the ARC, reaching 129.7 6 4.7% and 152.8 6
7.5% of the control levels, respectively (Figure 2B). Ghrelin ad-
ministration, however, did not induce NA release in transected
rats. Hindbrain noradrenergic neurons innervating the hypothal-
amus are implicated in mediation of the feeding response to
glucose deprivation (Ritter et al., 2001), suggesting that the NA
system in the brain contributes significantly to feeding regulation
and/or energy homeostasis. The present study demonstrates
that ghrelin, an orexigenic signal produced in the periphery, in-
creases DBH mRNA levels in the NTS and increases NA levels
within the ARC. These results suggest that noradrenergic inputs,
projecting from the hindbrain to the ARC, are critical for the feed-
ing behavior induced by peripheral ghrelin. This study, however,
has yet to elucidate whether peripheral ghrelin signals transmit-
ted via the vagal afferent pathway affect the NA system in the
ARC or whether ghrelin bound to the receptor present in the
area postrema or NTS stimulates it. To clarify this issue, further
examinations to evaluate NA overflow in the ARC of vagotom-
ized animals are needed.
CCK, an anorectic peptide produced by the gastrointestinal
tract, increases the firing rate of the vagal afferent fibers, and
thereby transmits satiety information to the NTS. Recently,
Sutton et al. showed that the CCK-induced reduction in feed-
ing is modulated by a melanocortinergic pathway through extra-
cellular signal-regulated kinase signaling in the NTS (Sutton325
S H O R T A R T I C L EFigure 3. The effects of either pretreatment with
adrenoceptor antagonists or disruption of DBH-
containing neurons on ghrelin-induced feeding
A) Effect of i.c.v.-administered a1 or a2 antagonists
on feeding induced by ghrelin (15 mg/kg). *p < 0.05,
**p < 0.005 versus rats given saline plus ghrelin.
B) Effect of i.c.v.-administered b1 or b2 antagonists
on feeding induced by ghrelin (15 mg/kg). *p <
0.005, **p < 0.001 versus rats given saline plus
ghrelin.
C) Food intake of rats treated with an a1 or a b2
antagonist after a single intracerebroventricular ad-
ministration of ghrelin (5 mg/kg). *p < 0.0005 versus
saline.
D) Effect of DSAP treatment on ghrelin-induced
feeding. *p < 0.0001.
E) Food intake of DSAP-treated rats after a single
intracerebroventricular administration of ghrelin
(5 mg/kg). *p < 0.0001.
Error bars represent the SEM.et al., 2005). There is also a report that fourth ventricular admin-
istration of the MC4-melanocortin receptor antagonist SHU9119
completely blocked the peripherally administered CCK-induced
decrease in feeding (Fan et al., 2004). These findings indicated
that the NTS is crucial for the integration of peripheral ascending
signals with descending signals from the hypothalamus that re-
late to feeding. The precise molecular mechanisms that underlie
the effect of peripheral ghrelin signals on NTS function remain to
be elucidated. To fully understand the noradrenergic pathway
from the NTS to the hypothalamus, further investigations into
the identities of the intracellular signaling systems in the NTS
that are mobilized by peripheral ghrelin, and the signals from
the forebrain that modulate peripheral ghrelin signaling in the
NTS are required.326NA can utilize at least four distinct receptor subtypes: a1, a2,
b1, and b2 (O’Dowd et al., 1989). We examined which of these
receptors was involved in ghrelin-induced feeding by treatment
with an antagonist for each adrenoceptor. Ghrelin-induced
feeding was attenuated in rats pretreated with either the specific
a1 antagonist prazosin or the specific b2 antagonist ICI 118, but
not the a2 antagonist yohimbine or the b1 antagonist atenolol
(Figures 3A and 3B) (n = 7 per group). After injection of these ad-
renergic antagonists intracerebroventricularly (i.c.v.), rats were
observed for behavioral signs of nausea (elongation of the
body, gaping, raising the tail, and lowering the belly to the floor),
ataxia, sedation, and anxiety (locomotion within the cage and
avoidance of the front of the cage). The rats did not exhibit
any of these signs during the testing period. We also testedCELL METABOLISM : OCTOBER 2006
Noradrenergic signaling in ghrelin-induced feedingthe orexigenic effect of centrally administered ghrelin in rats
treated with prazosin or ICI 118, as these antagonists may non-
specifically suppress feeding in response to ghrelin. Centrally
administered ghrelin increased feeding similarly in the prazosin-
and ICI 118-treated groups and the control group (Figure 3C).
This result suggests that although NA antagonists specifically
suppressed feeding induced by peripherally administered ghre-
lin, centrally administered ghrelin induces feeding by a mecha-
nism that is independent of the noradrenergic system. Consid-
ering that NA excites approximately 50% of the neurons in the
ARC, probably due to a direct postsynaptic response through
a1- or b-adrenoceptors (Kang et al., 2000), peripherally adminis-
tered ghrelin may activate NPY/AgRP neurons in the ARC
through the NA system. A recent study also suggested the pos-
sibility that the GABAergic system is involved in ghrelin-induced
feeding. Cowley et al. showed that ghrelin induced depolariza-
tion of ARC NPY neurons and hyperpolarization of ARC pro-
opiomelanocortin (POMC) neurons using hypothalamic slices
(Cowley et al., 2003). Given that NPY/AgRP neurons expressing
are GABAergic, central ghrelin may induce the release of GABA
from NPY axonal terminals and thereby modulate the activity of
postsynaptic POMC neurons.
NA exerts a variety of responses that depend on the type of
neurons and the expression of different adrenoceptor subtypes
(Nicoll et al., 1990). Infusion of exogenous NA can cause either
increases or decreases in food intake (references in Wellman,
2000), which may depend on the site of application or changes
in the numbers of adrenoceptors according to the circadian
cycle. For example, NA injection into the hypothalamic para-
ventricular nucleus (PVN) increases feeding through PVN a2-
adrenoceptors, whereas it decreases feeding through PVN
a1-adrennoceptors (Goldman et al., 1985; Wellman et al.,
1993). The circadian pattern in the number of a2-adrenoceptors
within the PVN exhibits a sharp increase in a2-adrenoceptors at
the onset of the dark phase, a time when feeding is greatly
enhanced. Taken together, it may be difficult to determine
whether microinjection of an NA agonist or antagonist into the
hypothalamic nuclei results in a physiologically significant ef-
fect. Therefore, in the present study, we focused on the role of
endogenous NA induced by peripherally administered ghrelin
in the control of food intake. We demonstrated that a1- and
b2-receptor antagonists attenuated feeding induced by ghrelin.
This result indicates that a1- and/or b2-adrenoceptors in the ARC
play an important role in peripheral ghrelin-induced feeding.
To eliminate NA innervation of the ARC, we used DSAP,
a monoclonal antibody specific for DBH, the enzyme that con-
verts dopamine into NA, conjugated to saporin (SAP) (Fraley
and Ritter, 2003). DSAP, an immunotoxin that allows an anti-
body against the NA synthetic enzyme DBH to selectively deliver
the saporin toxin, can successfully destroy hindbrain neurons
that contain DBH (Rinaman, 2003). Bilateral DSAP injections
into the ARC induced an approximately 70% reduction in
DBH-positive neurons in the NTS in comparison to the number
of DBH neurons present in rats treated with an SAP control so-
lution (data not shown). DSAP injections also completely dis-
rupted peripherally administered ghrelin-induced feeding
(Figure 3D) (n = 7 per group). We also tested the orexigenic effect
of centrally administered ghrelin in the DSAP-treated rats. Cen-
trally administered ghrelin increased feeding similarly in the
DSAP-treated group and the control group (Figure 3E) (n = 7
per group). This finding suggests that the noradrenergic systemCELL METABOLISM : OCTOBER 2006in the ARC is not involved in centrally administered ghrelin-
induced feeding.
There are several catecholaminergic neuronal cell groups in
the hindbrain. DBH-positive neurons projecting to the hypothal-
amus are found within the A2 cell group located in the caudal
medial and commissural NTS and the A1/C1 cell group located
in the ventrolateral medulla (VML). Most NA neurons within the
A2 group directly project to the hypothalamus, central nucleus
of the amygdala, and bed nucleus of the stria terminalis,
whereas the A2 NA neurons also project to these forebrain areas
in part via the A1/C1 group. As viscerosensory signals from the
gastrointestinal tract are carried to the caudal medial and com-
missural NTS via the vagal afferent pathway, NA neurons in A2
may be an integral component of the brainstem circuits that me-
diate ghrelin-induced feeding. Given the projection from the A2
group to the A1/C1 group, these integrative circuits would in-
clude a role for NA neurons in the VML. Our findings suggest
that NA neurons in the hindbrain are necessary to convey ghre-
lin-related orexigenic signals to the hypothalamus.
Innervation of NPY neurons by DBH-containing fibers
To examine the effect of peripheral ghrelin signals ascending
from the NTS on neurons in the ARC, we investigated DBH in-
nervation and ghrelin-induced Fos expression using unilateral
midbrain-transected rats as described previously (Ericsson
et al., 1994; Sawchenko, 1988). We compared DBH innervation
and Fos expression in the ARC ipsilateral and contralateral to
the lesion. Midbrain transections significantly decreased the
DBH-imunoreactive innervation ipsilateral to the lesion (Figures
4A and 4B). This finding is consistent with the fact that the as-
cending catecholamine input to the hypothalamus is largely uni-
lateral. In lesioned rats, peripherally administered ghrelin re-
sulted in a significant increase in Fos expression in the ARC
that was contralateral to the lesion (ipsilateral side, 24.3 6 1.8
neurons; contralateral side, 50.66 1.9 neurons; p < 0.001) (Fig-
ures 4C and 4D). When saline was injected i.v. to lesioned rats,
Fos expression did not differ significantly on the two sides of the
brain (ipsilateral side, 11.6 6 1.3 neurons; contralateral side,
11.96 1.0 neurons; p > 0.1) (data not shown). These results sug-
gest that the midbrain transections that were effective in reduc-
ing DBH-positive innervation blocked the response of neurons in
the ARC to peripherally administered ghrelin.
Electron microscope immunohistochemistry demonstrated
that NPY-immunoreactive perikaryon and dendritic process of-
ten received synapses from DBH-containing axon terminals
(Figures 4E–4G). Approximately 40%–50% of hypothalamic
NPY neuron innervation arises from catecholaminergic neurons
in the hindbrain (Everitt and Hokfelt, 1989). NPY, a potent orexi-
genic peptide, is thought to be the final mediator of ghrelin feed-
ing signals. To examine the anatomical linkage of NPY neurons,
which are activated by ghrelin, with DBH-immunoreactive fi-
bers, we performed immunohistochemistry. Intravenous ghrelin
injection significantly increased Fos expression in 53% of the
NPY neurons in the ARC (Figure 4H), in accordance with previ-
ous studies (Date et al., 2002). Triple labeling immunofluores-
cence demonstrated that 54% of these NPY neurons in the
ARC induced to express Fos by ghrelin treatment were inner-
vated by DBH-immunoreactive fibers (Figure 4I). These results
suggest that ghrelin signals activate NPY neurons via the norad-
renergic pathway ascending from the NTS to the ARC, resulting
in increased feeding.327
S H O R T A R T I C L EFigure 4. The effect of unilateral midbrain transections on ghrelin-induced Fos
expression and activation of NPY neurons by ghrelin via the catecholaminergic
pathways
A) DBH-immunoreactive fibers project to the ARC contralateral to the lesion.
B) DBH-immunoreactive innervation ipsilateral to the lesion decreases as com-
pared to that on the contralateral side.
C) Peripherally administered ghrelin (15 mg/kg) induces Fos protein expression
contralateral to the lesion.
D)Ghrelin-induced Fos expression ipsilateral to the lesion decreases as compared
to that on the contralateral side.
E) DBH-immunoreactive axon terminal making synapses with immunonegative
dendritic process (arrow, synapse).328The present study focused on the hypothesis that the neural
pathway from the brainstem to the ARC plays a crucial role in
transmitting peripheral ghrelin signals and peripheral ghrelin
regulates feeding at least partially via NA-mediated neuronal
transmission. Although the central circuits for feeding may
have been altered in response to bilateral midbrain transections
or DSAP treatment, the results shown here are consistent with
the hypothesis. The hypothesis, if correct, is a counterpoint to
the most widely accepted model for neuroendocrine energy bal-
ance regulation. We have shown previously that peripheral ghre-
lin-induced feeding is absent in either vagotomized or capsai-
cin-treated rats. We showed here that ghrelin-induced feeding
is also canceled in midbrain transected rats. Thus, it may
seem that peripheral ghrelin signals for starvation are transmit-
ted to the hypothalamus only via the vagal afferent pathway
and neural pathways from the NTS. However, we have to con-
sider the possibility that vagotomy and/or midbrain transections
affect several peripheral substances as well as central circuits
relative to feeding. In addition, the present study has yet to ad-
dress the direct relationship between peripheral ghrelin signals
via the vagal afferent pathway and the NA system in the ARC.
Taken together, it may be difficult to assert that peripheral ghre-
lin signals are transmitted only via the neural pathways. We,
therefore, think that the humoral pathway and the neural path-
way are important routes to convey peripheral energy balance
information to the brain. Very recently, we found that peripher-
ally administered leptin decreased 2 hr and 4 hr food intake in
vagotomized, midbrain transected, and sham-operated rats,
and the leptin-induced reduction in feeding was less pro-
nounced in vagotomized and transected rats than in the
sham-operated rats (unpublished data). These findings suggest
that the vagal afferent pathway and/or the ascending efferent
pathway from the brainstem to the hypothalamus are necessary
elements for the effectual action of leptin on feeding and energy
homeostasis. Feeding is regulated by a complicated interaction
of many orexigenic and anorectic signals; sophisticated interac-
tions between humoral pathways and neural pathways may be
necessary to maintain energy homeostasis. We have shown
that the central noradrenergic system is a candidate to mediate
peripheral ghrelin signals. Although the pathways linking periph-
eral ghrelin to NA transmission are likely to be more complicated
given the remarkable number of signals that provide input to the
NTS and ARC, we believe that this study provides an important
clue to understanding the feedback loops linking the brain and




We maintained male Wistar rats (Charles River Japan, Inc.), weighing 255.96
2.0 g, under controlled temperature and light conditions (0800–2000 hr light).
F) DBH-immunoreactive axon terminal making synapses with NPY-immunoreac-
tive dendritic process (arrow, synapse).
G) DBH-immunoreactive axon terminal making synapses with NPY-immunoreac-
tive perikaryon (arrow, synapse).
H) Intravenous administration of ghrelin (15 mg/kg) upregulates Fos expression in
NPY neurons of the ARC (arrows) (blue, Fos; green, NPY).
I) Fifty-four percent of ghrelin-activated NPY neurons receive projections from
DBH-immunoreactive fibers (arrows) (blue, Fos; green, NPY; red, DBH). g; Golgi
apparatus; 3v, third ventricle. The scale bar represents, respectively, 100 mm
(A and B), 200 mm (C and D), 400 nm (E–G), and 50 mm (H and I).CELL METABOLISM : OCTOBER 2006
Noradrenergic signaling in ghrelin-induced feedingFor feeding and microdialysis experiments, an intravenous cannula was im-
planted into the right jugular vein of each rat under anesthesia. We performed
unilateral or bilateral midbrain transections 5 days after implantation, as de-
scribed details in the Supplemental Experimental Procedures. To confirm
that the transection surgeries were successful, the brains were immuno-
stained using an anti-DBH antiserum diluted 1:1000 (Chemicon International,
Inc.) by the avidin-biotin complex method (Date et al., 1999) after the feeding
tests were completed (Figure S3A). To facilitate the penetration of a micro-
dialysis probe, a guide cannula (500 mm outside diameter; AG-12, Eicom)
was stereotaxically implanted 1.0 mm above the ARC (0.2 mm lateral to
the midline, 2.4 mm caudal to the bregma, and 9.0 mm ventral to the dura),
fixed to the skull with acrylic dental cement, and sealed with a dummy can-
nula (350 mm external diameter; AD-12, Eicom). To inject adrenergic receptor
antagonists into the rats, we implanted intracerebroventricular cannulae into
the lateral cerebral ventricle. To block noradrenergic innervation of the ARC,
we microinjected either a SAP-conjugated DBH-specific mouse monoclonal
antibodies (DSAP; Advanced Targeting Systems; 42 ng/0.2 ml in phosphate
buffer [pH 7.4], n = 6) or SAP-conjugated normal mouse IgG (SAP control so-
lution) (Advanced Targeting Systems; 8.82 ng/0.2 ml, n = 6) bilaterally into the
ARC (Ritter et al., 2001). Only animals exhibiting progressive weight gain after
these surgeries were used in subsequent experiments. All procedures were
performed in accordance with the Japanese Physiological Society’s guide-
lines for animal care.
Food intake
First, rat ghrelin (Peptide Institute, Inc.) at 0.1–100 mg/kg (100 ml), or saline
alone (100 ml) was administered i.v. at 1000 hr to ad libitum-fed rats that
had undergone a sham operation (n = 7 per group). Second, rat ghrelin (15
or 50 mg/kg [100 ml]) was administered i.v. to rats that had undergone bilateral
midbrain transection. Third, rat ghrelin (15 or 50 mg/kg [100 ml]) was adminis-
tered i.v. to rats that had been treated with either DSAP or SAP control solu-
tion. Fourth, ghrelin (5 mg/kg [10 ml]) was injected i.c.v. at 1000 hr into rats that
had undergone bilateral midbrain transections or sham operations, or into
rats that had been treated with either DSAP or SAP control solution. The
dose of centrally administered ghrelin (5 mg/kg) is often used as a standard
while investigating the effect of i.c.v.-administered ghrelin on food intake un-
der various conditions (Nakazato et al., 2001; Kamegai et al., 2000; Toshinai
et al., 2003). Thus, this dosage is recognized as the most appropriate in con-
stantly inducing food intake when administered i.c.v. Therefore, this dosage
was also selected as a standard to evaluate i.c.v. administered ghrelin in-
duced feeding. After ghrelin injection, rats were immediately returned to their
cages. Two hour food intake was then measured.
Quantitative RT-PCR
Two hours after intravenous administration of ghrelin (15 mg/kg) or saline to
rats, total RNA was extracted from the NTS using TRIZOL Reagent (Invitro-
gen Corp.). Quantitative RT-PCR for DBH was conducted with a LightCycler
system (Roche Diagnostics) using a LightCycler-Fast Start DNA Master
SYBR Green I kit (Roche) and the following primer set for rat DBH: 50-
CTAGGGCCCTGGGCGCCAAGGCATT-30 and 50-GCCAGAGGAGTCGCG
CCGGCCTT-30. Known amounts of DBH cDNA were used to obtain a stan-
dard curve. Rat rRNA levels were also measured as an internal control.
Microdialysis
One week after midbrain transection, the rats were lightly anesthetized with
isoflurane, and the dummy cannula was replaced with a microdialysis probe.
The tip of the microdialysis probe, covered with hollow fibers (1.0 mm in
length, 220 mm external diameter, regenerated cellulose membrane with
a molecular weight cutoff of 48 kDa; Eicom), was set to extend 1 mm beyond
the guide cannula to reach the ARC. Microdialysis was performed under free-
moving conditions. A microinfusion pump was used to continually perfuse
the probe with modified physiological Ringer’s solution (147 mM NaCl, 4
mM KCl, and 2.3 mM CaCl2 [pH 6.5]) at a constant flow rate of 1 ml/min. To
measure NA, chromatographic analysis of dialysates was carried out by
HPLC with electrochemical detection as described previously (Ishizuka
et al., 2000). The perfusate from the ARC was automatically injected into
the HPLC every 20 min. After a 3 hr stabilization period, baseline NA levels
were assessed in four consecutive dialysate samples. At the end of each
experiment, rats were sacrificed with an overdose of pentobarbital sodium;
the brains were then fixed in 10% neutral buffered formalin. Placement ofCELL METABOLISM : OCTOBER 2006the microdialysis probe was verified histologically in 40-mm cresyl violet-
stained coronal sections (Figure S3B).
Effect of adrenoceptor blockers on ghrelin-induced feeding
At 0930 hr, rats were i.c.v. administered either vehicle alone (saline, n = 6) or
one of the specified adrenergic receptor antagonists: prazosin (selective a1
antagonist: 0.6 or 1.2 mg/kg, n = 6 each) (Sigma Chemical Co.), yohimbine
(selective a2 antagonist: 1.0 mg/kg, n = 6) (Sigma), atenolol (selective b1 an-
tagonist: 0.8 mg/kg, n = 10) (Sigma), or ICI 118 (selective b2 antagonist: 0.5
or 1.0 mg/kg, n = 6 each) (Sigma). Thirty minutes after adrenergic receptor an-
tagonist injection, ghrelin (50 mg/kg) was administered intraperitoneally to
rats; 2 hr food intake was measured. We also tested the orexigenic effect
of centrally administered ghrelin in rats that had been injected with prazosin
or ICI 118. Thirty minutes after prazosin (1.2 mg/kg, n = 6) or ICI 118 (1.0 mg/kg,
n = 6) injection, ghrelin (5 mg/kg) was administered i.c.v. to rats; 2 hr food
intake was measured. The rats fasted between the two injections.
Immunohistochemistry
Ghrelin (15 mg/kg) or saline was injected i.v. into rats 90 min before transcar-
dial perfusion with fixative containing 4% paraformaldehyde (n = 5 per
group). The brains of animals were then cut into 20-mm thick sections. The
sections were first incubated with anti-c-Fos antiserum (1:500, Santa Cruz
Biotechnology), and then with Alexa Flour 350-conjugated donkey anti-
goat IgG (Molecular Probes, Inc.). Next, samples were incubated with
anti-NPY antiserum (1:500, ImmunoStar, Inc.), then with Alexa Flour 488-
conjugated chicken anti-rabbit IgG (Molecular Probes, Inc.). Finally, the
samples were incubated with anti-DBH antiserum (1:1,000, Chemicon Inter-
national, Inc.), then with Alexa Flour 568-conjugated goat anti-mouse IgG
(Molecular Probes, Inc.). Samples were then observed under a BH2-RFC mi-
croscope (Olympus Corp.). We counted the number of Fos-immunoreactive
cells in the bilateral ARCs (bregma: 22.30 to 23.30 from Paxinos and
Watson’s rat brain atlas). Sections from unilaterally transected rats were
also incubated with anti-DBH antiserum, and then with Alexa Flour 568-
conjugated goat anti-mouse IgG (Molecular Probes, Inc.). A significant
(>60%) depletion of DBH-immunoreactive fibers was determined by semi-
quantitative comparison of the strength of the DBH-positive innervation of
the ARC ipsilateral and contralateral to the lesion by two independent ob-
servers (Sawchenko, 1988). Sections from unilaterally transected rats were
incubated with anti-c-Fos antiserum (Santa Cruz Biotechnology), and then
stained by the avidin-biotin complex method (Date et al., 1999). The number
of Fos-immunoreactive cells was compared in the ARC ipsilateral and con-
tralateral to the letion. Fos-expressing cells of the ARC in a 0.7-mm right
triangle (0.245 mm2) were counted in every fifth section (ten tissue sections
per rat) using a cell-counting program written for NIH Image (v1.62; NIH).
Electron microscope immunohistochemistry
Three Wistar rats were perfused as described above. The brain was cut into
30–40 mm thick sections using an Oxford vibratome (Oxford Instruments).
Electron microscope immunohistochemistry was performed using anti-
NPY antiserum and anti-DBH antiserum as described previously (Toshinai
et al., 2003).
Statistical analysis
We analyzed groups of data (means 6 SEM) using analysis of variance
(ANOVA) and post hoc Fisher tests. p values less than 0.05 were considered
to be significant (two-tailed tests).
Supplemental data
Supplemental Data include Supplemental Results, Supplemental Experi-
mental Procedures, Supplemental References, and three figures and can
be found with this article online at http://www.cellmetabolism.org/cgi/
content/full/4/4/323/DC1/.
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